Advert - Galderma

For offering a pecuniary advantage to health professionals in connection with attendance at a promotional meeting, Galderma was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards 

Clause 18.1 - Offering a pecuniary advantage to health professionals in connection with the promotion of medicines.

The Code of Practice Panel was concerned about Galderma’s poor knowledge of the Code and/or a reckless attitude towards its application. The Panel reported Galderma to the Code of Practice Appeal Board which publicly reprimanded the company; it also required an audit of Galderma’s procedures.

Galderma subsequently declined the audit and indicated that it no longer wished to accept the jurisdiction of the Authority.

The Appeal Board removed Galderma from the list of non member companies that have agreed to comply with the Code and accept the jurisdiction of the Authority.

The PMCPA thus can no longer accept responsibility for Galderma under the Code.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has been so informed.

Advert - November 2014